These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37204189)

  • 1. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.
    Oerlemans S; Efficace F; Shamieh O; Cardoso Borges F; de Jong C; Dong D; Lehmann J; Malak S; Petranovic D; Scholz CW; Caocci G; Molica S; Griskevicius L; Nagele E; Bredart A; Carvalho E; Xochelli A; Agelink van Rentergem J; Alrjoob W; Mueller A; Freitas AC; Cocks K; Creutzberg C; Kyriakou C; van de Poll-Franse L
    Blood Adv; 2023 Nov; 7(22):7045-7055. PubMed ID: 37738090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort.
    Anota A; Basset M; Charton E; Bommier C; Efficace F; Dupuis J; Cottone F; Bouabdallah KK; Mollevi C; Ysebaert L; Winter A; Bijou F; Préau M; Chauchet A; Bernier A; Fornecker LM; Hafirassou H; Carras S; Lachenal F; Lionne-Huyghe P; Detourmignies L; Leyronnas C; Drénou B; Peyrou SLG; Abraham J; Monnereau A; Fouillet L; Morschhauser F; Rossi C; Belot A; Ghesquières H
    Eur J Cancer; 2024 Sep; 208():114210. PubMed ID: 39002346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
    Oerlemans S; Efficace F; Kieffer JM; Kyriakou C; Xochelli A; Levedahl K; Petranovic D; Borges FC; Bredart A; Shamieh O; Gziskevicius L; Lehmann J; Scholz CW; Caocci G; Molica S; Stamatopoulos K; Panteliadou AK; Papaioannou M; Alrjoob W; Baliakas P; Rosenquist R; Malak S; Miranda A; Cocks K; van de Poll-Franse L;
    Br J Haematol; 2022 May; 197(4):431-441. PubMed ID: 35255152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation and Pilot Validation of the EORTC QLQ-NHL-HG29 Module in Indian Languages (Hindi and Marathi) for Use in Indian Patients with Non-Hodgkin's Lymphoma.
    Patil R; Palwe V; Pandit P; Kate S; Paleja N; Badarkhe G; Wasekar N; Bhamre R; Yasam RV; Nagarkar R
    South Asian J Cancer; 2023 Apr; 12(2):190-198. PubMed ID: 37969689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer.
    Wheelwright S; Darlington AS; Fitzsimmons D; Fayers P; Arraras JI; Bonnetain F; Brain E; Bredart A; Chie WC; Giesinger J; Hammerlid E; O'Connor SJ; Oerlemans S; Pallis A; Reed M; Singhal N; Vassiliou V; Young T; Johnson C
    Br J Cancer; 2013 Aug; 109(4):852-8. PubMed ID: 23868003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
    Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26.
    Arraras JI; Giesinger J; Shamieh O; Bahar I; Koller M; Bredart A; Costantini A; Greimel E; Sztankay M; Wintner LM; de Sousa MC; Ishiki H; Kontogianni M; Wolan M; Kikawa Y; Lanceley A; Gioulbasanis I; Harle A; Zarandona U; Kulis D; Kuljanic K;
    Health Qual Life Outcomes; 2024 Oct; 22(1):87. PubMed ID: 39385305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
    Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
    Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
    Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
    Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study.
    Halkett GKB; Wigley CA; Aoun SM; Portaluri M; Tramacere F; Livi L; Detti B; Arcangeli S; Lund JA; Kristensen A; McFadden N; Grun A; Bydder S; Sackerer I; Greimel E; Spry N;
    Radiat Oncol; 2018 Aug; 13(1):162. PubMed ID: 30157890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.
    Sodergren SC; Johnson CD; Gilbert A; Darlington AS; Cocks K; Guren MG; Rivin Del Campo E; Brannan C; Christensen P; Chu W; Chung H; Dennis K; Desideri I; Gilbert DC; Glynne-Jones R; Jefford M; Johansson M; Johnsson A; Juul T; Kardamakis D; Lai-Kwon J; McFarlane V; Miguel IMC; Nugent K; Peters F; Riechelmann RP; Turhal NS; Wong S; Vassiliou V;
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1155-1164. PubMed ID: 36402360
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.